Biotech
Aug. 11, 2011
Stephen C. Ferruolo
These are trying times for entrepreneurs in the life science industry.
"We're not seeing a lot of startups with a lot of financing tied to them," Ferruolo said. "It's a challenge. The regulatory hurdles are high and there are people concerned that they are not predictable."
So he spends part of his time counseling companies on how to "stay afloat."
"We're helping them with small partne...
To continue reading, please subscribe.
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In